Is N-cadherin expression important in ductal carcinoma?

Southern Medical Journal

Volumn 101, Issue 5, 2008, Pages 470-475

  King, Judy A ^a   Shevde, Lalita A ^b   Ofori Acquah, Solomon ^b   Watkins, Gareth ^b   Jiang, Wen G ^b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Breast cancer; Cell adhesion; Metastasis; N cadherin; Prognosis

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NERVE CELL ADHESION MOLECULE;

ARTICLE; BREAST CARCINOMA; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LONG TERM CARE; LYMPH NODE METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 43149093543     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31816c0112     Document Type: Article

References (22)

1. Breast Cancer Facts & Figures. Atlanta, GA, American Cancer Society, 2007, pp 1-32.
2. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001;61:3819-3825.
3. Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 2004;48:463-476.
4. Hazan RB, Phillips GR, Qiao RF, et al. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-790.
5. Kovacs A, Dhillon J, Walker RA. Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 2003;56:318-322.
6. Peralta Soler A, Knudsen KA, Salazar H, et al. P-cadherin expression in breast carcinoma indicates poor survival. Cancer 1999;86:1263-1272.
7. King JA, Ofori-Acquah SF, Stevens T, et al. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 2004;6:R478-R487.
8. Jiang WG, Douglas-Jones A, Mansel RE. Levels of expression of lipoxygenases and cyclooxygenase-2 in human breast cancer. Prostaglandins Leukot Essent Fatty Acids 2003;69:275-281.
9. Jiang WG, Douglas-Jones A, Mansel RE. Expression of peroxisome- proliferator activated receptor-gamma (PPARgamma) and the PPAR-gamma co-activator, PGC-1, in human breast cancer correlates with clinical outcomes. Int J Cancer 2003;106:752-757.
10. Jiang WG, Watkins G, Lane J, et al. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9:6432-6440.
11. Parr C, Watkins G, Mansel RE, et al. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res 2004;10:202-211.
12. Al-Rawi MA, Rmali K, Watkins G, et al. Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer 2004;40:494-502.
13. Davies G, Cunnick GH, Mansel RE, et al. Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 2004;21:31-37.
14. Salhab M, Reed MJ, Al Sarakbi W, et al. The role of aromatase and 17-I(2)-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Res Treat 2006;99:155-162.
15. Nazarenko IA, Bhatnagar SK, Hohman RJ. A closed tube format for amplification and detection of DNA based on energy transfer. Nucleic Acids Res 1997;25:2516-2521.
16. Somlyo AV, Bradshaw D, Ramos S, et al. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun 2000;269:652-659.
17. Cunnick GH, Jiang WG, Gomez KF, et al. Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model. Biochem Biophys Res Commun 2001;288:1043-1046.
18. Hazan RB, Kang L, Whooley BP, et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 1997;4:399-411.
19. Nieman MT, Prudoff RS, Johnson KR, et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-644.
20. King J, Stevens T, Shevde L, et al. N-cadherin expression inversely correlates with local recurrence and death: a retrospective study of ductal carcinoma patients. Breast Cancer Res Treat 2006;100:S271.
21. Nagi C, Guttman M, Jaffer S, et al. N-cadherin expression in breast cancer: correlation with an aggressive histologic variant - invasive micropapillary carcinoma. Breast Cancer Res Treat 2005;94:225-235.
22. Paredes J, Milanezi F, Viegas L, et al. P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast. Virchows Arch 2002;440:16-21.